| HISTORICAL OVERVIEW
Sac1 was identified more than 25 years ago in a genetic screen for suppressors of actin defects in the budding yeast Saccharomyces cerevisiae.
14 sac1 yeast mutants are viable, but cold sensitive, and they display disorganized intracellular actin, as well as chitin accumulation at the cell surface. sac1 mutants also exhibit decreased secretion associated with increased transit time within the secretory pathway. Concurrently, Sac1 was identified in a screen for suppressors of mutations in the yeast secretory gene sec14, which encodes a Golgi-localized PI transfer protein (PITP) that shuttles PI and phosphatidylcholine (PC) between membranes in vitro and is essential for establishing
proper Golgi membrane composition and secretory function. [15] [16] [17] Sac1 also interacts genetically with 6 other SEC genes (sec6, sec9, sec17, sec18, sec21, sec23) involved in trafficking between the endoplasmic reticulum (ER), Golgi and PM. 15 More recently, a screen for mutants with multiple-drug sensitivities also identified Sac1. 18 As sac1 mutants are insensitive to osmotic stress (a hallmark of cytoskeletal or cell wall defects), this sensitivity is probably a consequence of effects on membrane integrity and permeability. Thus, although it was proposed that Sac1 might provide a link between intracellular trafficking and the actin cytoskeleton, the main function of Sac1 appears associated with membrane homeostasis within the cell.
Early biochemical studies determined that Sac1 copurifies with fractions containing ER membranes, suggesting a role in ER function. 19 Indeed, yeast sac1 mutants are deficient in ATP transport into the ER and display ER-specific defects in protein translocation and folding. 20, 21 Initially, this led to the idea that Sac1 was an ATP transporter. However, subsequent tests in vitro using recombinant Sac1
protein incorporated into phospholipid vesicles demonstrated this was not the case, 21 and the requirement for Sac1 in ATP transport remains unresolved. 22 Yeast sac1 mutants were shown to be inositol auxotrophs, although they display no defects in INO1 expression, inositol biosynthesis or incorporation of inositol into PI. 19, 23 At the time, this was a novel form of inositol auxotrophy that hinted at a role for Sac1 in metabolism of inositol phospholipids. Cloning of the mammalian PIP phosphatase synaptojanin and alignment of its sequence with that of Sac1 revealed a highly conserved region, further implicating Sac1 in PIP metabolism. [24] [25] [26] [27] Indeed, several independent studies revealed sac1 mutants show significant alterations in multiple PIP species, in particular a gross accumulation of PI4P, 23, [26] [27] [28] suggesting Sac1 might act as a PI 4-phosphatase.
3 | SAC1 PROTEIN CHARACTERIZATION
| Sac1 expression, distribution, conservation and genetics
Sac1 is conserved in its protein sequence, subcellular localization and function. Budding yeast Sac1 is a 65 kDa, unglycosylated integral membrane protein with low-level expression that is present at ER and Golgi membranes. 19, 29 Rat and mouse Sac1 proteins are ubiquitously expressed in adult and embryonic tissues, with highest expression in Purkinje cells, have 35% sequence identity with yeast Sac1
and are also enriched at ER and Golgi membranes. 30, 31 Drosophila Sac1 is expressed in all tissues and stages of development, shows 47% identity with mammalian Sac1, and associates with ER and Golgi membranes. [32] [33] [34] Human Sac1 shares 32% and 95% identity with yeast and rat Sac1, respectively, and is also present at ER and Golgi membranes. 35 Notably, ectopic expression of rat, mouse or human Sac1 complements phenotypes associated with loss of yeast Sac1, including effects on PIP levels, inositol auxotrophy and cold sensitivity. 30, 31, 35 Sac1 is essential in flies and mice, but largely dispensable for growth in yeast. In Drosophila, loss of Sac1 causes embryonic lethality due to defects in dorsal closure (DC). 36 In mice, Sac1 ablation leads to preimplantation lethality. 31 Furthermore, knockdown of mammalian Sac1 by siRNA in various cell lines compromises cell In the major pathway, PI4Ks phosphorylate PI to produce PI4P. PI4P can be dephosphorylated by Sac1 or further phosphorylated by PI4P5Ks to produce PI(4,5)P 2 . PI(4,5)P 2 can be phosphorylated by class I PI3Ks to produce PI(3,4,5)P 3 or dephosphorylated by 5-phosphatases to replenish PI4P. PI(3,4,5)P 3 is dephosphorylated by the 3-phosphatase PTEN to produce PI(4,5)P 2 viability and growth. 31, 37 It is interesting that Sac1 is not essential in yeast, 14, 15 given its vital role in other organisms. Double mutant analysis with the synaptojanin-like phosphatase Inp53 revealed that Inp proteins play a compensatory role in sac1 mutant yeast. 28 It is possible that Inp proteins compensate for loss of yeast Sac1 by dephosphorylating PI4P that accumulates in sac1 mutants. If so, it appears that multicellular organisms have lost this compensatory system.
| Sac1 catalytic activity and specificity
Based on early genetic and biochemical studies, it was proposed that Sac1 regulates PIP signaling. 15, 19, 24, 38 Indeed, Sac1 contains a conserved~500 amino acid domain (termed the SAC domain) that has PIP phosphatase activity in vitro. 26 This domain is present in yeast and mammalian synaptojanin family phosphatases, as well as Sac1 and the related phosphatases Inpp5F/Sac2 and Fig4/Sac3. [25] [26] [27] 39 The SAC domain contains 7 highly conserved motifs that define catalytic and regulatory regions of the phosphatase (Figure 2A -C). These include the catalytic core CX 5 R(T/S) located in conserved motif 6.
In vitro studies revealed that mouse and yeast Sac1 can dephosphorylate PI3P, PI4P and PI(3,5)P 2 , while displaying no catalytic activity toward PI(4,5)P 2 or PI(3,4,5)P 3 . 26, 30 In binding studies, human
Sac1 shows highest affinity for PI4P and PI3P, moderate affinity for PI(3,5)P 2 and PI(3,4,5)P 3 and low affinity for PI(3,4)P 2 and PI(4,5)P 2 .
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In vitro, human Sac1 dephosphorylates PI4P and to a lesser extent PI3P, while having no activity toward PI(3,5)P 2 . Overall, Sac1 exhibits phosphatase activity towards isolated phosphate groups, whereas
PIPs with adjacent phosphate groups (eg, PI(4,5)P 2 ) are resistant to Sac1 dephosphorylation.
Although Sac1 is capable of dephosphorylating multiple PIP species in vitro, in vivo studies revealed that Sac1 prefers PI4P as a substrate. In yeast cells growing at steady state, sac1 mutants show a 6-to 19-fold increase in PI4P, 2-to 2.5-fold increase in PI3P and 2.5-to 7-fold increase in PI(3,5)P 2 , 23, 26, 28, 40 whereas PI(4,5)P 2 levels were reported as unchanged, 23 slightly decreased 26 or decreased up to 5-fold. 28, 40 In Drosophila, sac1 knockdown cells and clones of cells mutant for sac1 exhibit a dramatic increase in PI4P levels, as detected by immunostaining, whereas PI(4,5)P 2 and PI3P levels appear unchanged. 34, 41 Similarly, in human cell lines, knockdown of Sac1 leads to a 30% increase in PI4P, as monitored by the FAPP PI4P-binding pleckstrin homology domain (PH-FAPP). 31 In yeast, specificity of Sac1 for PI4P was confirmed in pulse-chase experiments employing a temperature-sensitive (ts) allele of sac1 (sac1 ts ).
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When shifted to the nonpermissive temperature, sac1 ts cells display a 7-fold increase in PI4P, whereas other PIPs are only slightly affected. This differs from steady-state sac1 mutant cells and shows that Sac1 primarily turns over a newly synthesized pool of PI4P in vivo. Thus, the effect on other PIPs is probably an indirect consequence of ongoing Sac1 loss.
| Sac1 protein structure and topology
Topological studies in yeast identified Sac1 as a type II transmembrane protein, with 2 C-terminal transmembrane domains (TMD) that anchor it in the membrane. 29 This creates a "J" topology that allows the N-and C-terminal ends to face the cytosol ( Figure 2D) . Mammalian Sac1 shows a similar structure and "J" topology. 30, 35 The structure of Sac1 is distinct from other SAC domain-containing proteins, which lack TMDs. Mammalian Sac1 contains a putative leucine zipper (LZ) motif at its N-terminus and a coat protein I (COPI) binding motif (KEKIDD) at its extreme C-terminus, which are essential for Sac1 localization at the Golgi and ER, respectively 35, 42 ( Figure 2C ).
Elucidation of the yeast Sac1 crystal structure yielded interesting clues regarding Sac1 function and enzymatic regulation. The structure of the first 503 amino acids of yeast Sac1 (which includes the entire SAC domain) reveals N-and C-terminal subdomains 39 ( Figure 2A ). 39 This suggests Sac1 may require activation to bring the catalytic residues close enough for hydrolysis to occur.
Based on the crystal structure, a peptide stretch of~70 residues (residues 453-522) in SacC located between the catalytic motif and the first TMD (TMD1) was predicted to be unstructured 39 ( Figure 2A ). This region was proposed to act as a flexible linker, allowing the Sac1 catalytic domain to access and dephosphorylate PI4P in trans on apposing membranes (up to 20 nm away). 39, 43 However, more recent Sac1 structure-function studies demonstrated that a significant portion (residues 461-511) of this region is required for PI4P recognition and Sac1 phosphatase activity. 44 Thus, sequences available as a flexible linker may not be long enough for PI4P dephosphorylation in trans. Hence, it appears that Sac1 acts exclusively in cis in vivo.
| REGULATION OF PI4P BY SAC1 AND PI4KS IN VIVO
Although normally enriched at the Golgi and PM, PI4P is detected to some degree on most intracellular membranes. 6, 9, [45] [46] [47] [48] The presence of multiple, distinct PI4P pools is dictated by PI4Ks. [67] [68] [69] [70] [71] [72] PI4KIIα and PI4KII also localize to the TGN, where they participate in post-Golgi trafficking, 5, 6, 70 whereas PI4KIIβ and Lsb6 are also found at the PM. [73] [74] [75] [76] The genetics of PI4Ks differs in different organisms. In yeast, Stt4 and Pik1 are essential, whereas Lsb6 is dispensable. 55, 74 In Drosophila, PI4KIIIα is essential, but flies lacking Fwd or PI4KII are viable. 62, 65, 70 In mice, disruption of PI4KIIIα causes embryonic lethality, 59 whereas PI4KIIα mutant mice are viable, but develop late onset neurodegenerative disease. 77 This raises the question of whether Sac1 controls PI4P generated by each of the PI4Ks.
In yeast, there is conflicting evidence regarding the pool of PI4P regulated by Sac1. Early studies suggested Sac1 dephosphorylates a Pik1-generated PI4P pool because treatment of sac1 mutant cells with wortmannin (which inhibits Stt4) did not prevent PI4P accumulation. 23 In support of this, Pik1 overexpression and Sac1 loss cause similar defects in anterograde trafficking (eg, excessive trafficking of Chs3 to the cell periphery). 78 However, additional studies revealed that the relationship between yeast Sac1, Stt4 (PI4KIIIα) and Pik1 (PI4KIIIβ) is more complex. Double mutant analysis demonstrated that stt4 mutant defects are suppressed by sac1 ts , whereas pik1 mutant defects are not. 28 Furthermore, sac1, stt4 double mutants have normal PI4P levels, whereas sac1, pik1 double mutants have increased PI4P, similar to sac1 single mutants. 28, 79 Based on these results, it was proposed that yeast Sac1 primarily turns over Stt4-generated PI4P and that the pool of PI4P that accumulates in sac1 mutants cannot substitute for Pik1-generated PI4P. 28 These discrepancies probably reflect the inability of Sac1 to access the Pik1-generated pool of PI4P at the Golgi unless cells are starved, as described below.
In Drosophila, knockdown of PI4KIIIα rescues the increased PI4P levels in sac1 mutant clones in eye and wing imaginal discs, whereas knockdown of Fwd (PI4KIIIβ) does not. 41 Hence, PI4KIIIα appears to generate PI4P that is dephosphorylated by Sac1 in Drosophila, at least in the context of eye and wing imaginal discs. In mammalian cells, Sac1 was originally identified at ER membranes. 30 Given that
PI4KIIIα is also localized at the ER, it was postulated that Sac1 uses PI4KIIIα-generated PI4P as a major substrate. However, this has yet to be conclusively tested in mammalian cells. Based on combined evidence from yeast, Drosophila and mammalian cells, it seems clear that Sac1 regulates Stt4-generated PI4P.
However, this does not rule out a role for Sac1 in countering the activity of other PI4Ks. Indeed, it seems likely that Sac1 has the ability to regulate multiple PI4K-generated PI4P pools, depending on the cell type, context and growth conditions.
| SAC1 FUNCTION IN DIFFERENT INTRACELLULAR COMPARTMENTS
In Sac1-deficient cells from yeast, flies or mammals, PI4P accumulates not only at ER and Golgi membranes, but it is also enriched at peripheral compartments, including secretory vesicles, PM and lysosomes. 34,37,79l,80-82 This could be due to PI4P-rich membranes moving from the ER and Golgi to more distal compartments or it could be due to a lack of Sac1 phosphatase activity directly at these compartments. Given the increase and aberrant distribution of PI4P
in Sac1-depleted cells, Sac1 clearly functions to prevent random dispersal of PI4P and helps maintain PI4P pools in specific cellular locations. 79, 80 When Sac1 is lost, multiple PI4P pools are affected and the functional identity of many intracellular compartments is compromised.
| Dynamic regulation of Sac1 localization: ERGolgi shuttling
Cells dynamically control Sac1 enrichment at ER or Golgi membranes in response to cellular and external cues such as nutrient availability.
Yeast Sac1 regulates PI4P levels in response to growth conditions ( Figure 3A , B). In the presence of glucose, Sac1 is enriched at the ER, whereas upon glucose deprivation, or when cells enter stationary phase, Sac1 moves to the Golgi 81,83 ( Figure 3B ). This reversible and rapid shuttling of Sac1 between ER and Golgi membranes has many cellular benefits. In the presence of glucose, yeast cells undergo rapid growth, which requires efficient PI4P-dependent post-Golgi secretory trafficking to the bud. 55, 61, 78, 84 ER-localized Sac1 generates a steep PI4P gradient from the TGN to the ER ( Figure 3A) , 81, 83 which enables proper oligosaccharide biosynthesis and trafficking at the ER, while simultaneously allowing sufficient Golgi PI4P for polarized secretion.
In contrast, in the absence of glucose, protein synthesis, secretory trafficking and cell growth are reduced. 85 Under these conditions, Golgi-localized Sac1 generates a reverse gradient, with high PI4P at ER membranes and low PI4P at the Golgi 81,83 ( Figure 3B ). Decreased
Golgi PI4P halts secretory trafficking, and increased ER PI4P downregulates ER function, allowing the cell to preserve its limited resources.
In this way, Sac1 localization can control membrane-specific PI4P enrichment in response to growth conditions.
The growth condition-specific changes in Sac1 distribution help explain conflicting evidence regarding whether Stt4 or Pik1 produces the pool of PI4P that accumulates in yeast sac1 mutants. In the presence of glucose, and during rapid cell growth, Sac1 confines PI4P to the Golgi by turning over Stt4-specific PI4P pools outside the Golgi, whereas under glucose-starved conditions, Sac1 reduces Pik1-generated PI4P at the Golgi 81 ( Figure 3A , B). Interestingly, Pik1 localization at the Golgi is also sensitive to growth conditions. In the presence of glucose, Pik1 localizes to the Golgi with the help of its regulatory subunit Frq1 and generates PI4P 86, 87 ( Figure 3A ). Upon glucose removal, Pik1 and Frq1 are released into the cytoplasm, preventing further PI4P synthesis at the Golgi 81 ( Figure 3B ). Thus, both
Sac1 and Pik1/Frq1 control Golgi PI4P levels in response to cell growth and nutrient availability.
During exponential growth, yeast Sac1 is sorted into the Golgito-ER retrograde pathway by binding to the ER-resident protein
Dpm1
. 83 The C-terminus of Sac1 (including TMD2) Interestingly, another MAPK has been implicated in Sac1 Golgi localization in neurons. c-Jun N-terminal kinase 3 (JNK3) is a MAPK and JNK p54 isoform that is abundant in the brain and important for the neuronal stress response. 95, 96 Excitotoxicity in primary rat neurons causes JNK3 to accumulate at the Golgi, where it binds and recruits Sac1, leading to decreased Golgi PI4P and reduced secretory trafficking. [97] [98] [99] Other mammalian JNK isoforms contain homologous sequences that could perform an analogous function in cell types where JNK3 is absent. 98 Thus, whereas p38 MAPK targets mammalian Sac1 to the ER and drives anterograde trafficking in response to growth factors, JNK3 MAPK traps Sac1 at the Golgi, thereby preventing anterograde trafficking in response to neuronal stress. 29 In contrast, sac1 mutants display increased PI4P at ER membranes, resulting in impaired protein processing. 79 Together, these data indicate that reduced levels of PI4P at the ER are tolerated, whereas excess PI4P interferes with normal ER homeostasis.
| Sac1 in the ER
The ER is the main site of lipid and protein production in the cell. Together, these results indicate that Sac1 activity at the ER is required for efficient oligosaccharide biosynthesis and proper secretory trafficking at the ER.
| Sac1 in the Golgi
Immunofluorescence studies in yeast, fly, mouse and human cells have shown that Sac1 is present on Golgi membranes. 19, [29] [30] [31] 34, 35 The Golgi is made up of cis, medial and trans-Golgi compartments or cisternae. PI4P levels are highest at the trans-Golgi and decrease toward the cis-Golgi. 5, 6, 37, 104 Sac1 plays a crucial role in establishing and maintaining this spatial distribution of Golgi PI4P. 37 ImmunoEM of HeLa cells shows that Sac1 is specifically localized to cis and medial
Golgi compartments (where PI4P is low), but is absent from the transGolgi and TGN (where PI4P is high). 37 When Sac1 is knocked down in mammalian cells, the Golgi becomes enlarged and fragmented 31, 37 and the graded distribution of PI4P between Golgi compartments is lost. 108, 109 Furthermore, the ability of Vps74 to bind Sac1 is critical for maintenance of Golgi glycosyltransferases. 44 As a result, it was proposed that Vps74 is a PI4P sensor that directs PI4P metabolism by interacting with Sac1 at cis/medial Golgi compartments. This allows cis-and medial-Golgi compartments to be differentiated from the trans-Golgi and TGN, and maintains cisternal identity.
| Sac1 function at membrane contact sites
Membrane contact sites (MCS) are regions where membranes of 2 distinct organelles are tethered and closely apposed. ( Figure 4A ). This countertransport is important because it allows ER- In addition to Scs2 and Scs22, 4 other proteins have been identified as ER-PM tethers in yeast. 122 These include Ist2 (which is related to TMEM16 ion channels) and the 3 tricalbins (Tcb1, 2, 3; orthologs of extended synaptotagmins, E-Syts). 123, 124 Deletion of all 6 tethering proteins causes a 7-fold increase in PI4P (with PI4P accumulating at the PM), collapse of ER structure, and UPR induction. 122 This highlights the importance of ER-PM contact sites, not only for maintaining PIP signaling at the PM, but also for ER homeostasis.
| ER-Golgi contact sites
A similar arrangement, with the same key players, occurs at ER-Golgi contact sites, but PI4P is exchanged for sterols instead of PS ( Figure 4B ). Mammalian OSBP and yeast Osh4 are involved in countertransport of sterols and PI4P. 114, 115 As with ER-PM contact sites, VAP acts as a membrane tether at ER-Golgi contact sites and is required for OSBP/Osh4 recruitment. 115, 119 This allows sterol/PI4P
exchange, followed by Sac1-dependent turnover of PI4P at the ER to produce PI. In budding yeast, the PITP Sec14 can then transfer PI back to the Golgi, while transferring PC to the ER. 114 Replenishing PI at the Golgi is required for subsequent PI4P production, as well as for complex sphingolipid biosynthesis. In this way, the ability of Sac1 to hydrolyze PI4P and maintain a PI4P gradient between Golgi and ER membranes is harnessed to drive sterol enrichment at the Golgi. 
| Activity regulation through subcellular localization of Sac1
Sac1 activity is also controlled by its localization at ER, Golgi and MCS. Sac1 subcellular distribution is determined by many factors, including its own sequence and structural motifs, its binding partners, nutrient availability or growth conditions, and PIP levels. For example, Sac1 ER localization requires the SacC domain 30, 35, 81 (Figure 2A-C) .
In mammals, this domain contains a coat protein I (COPI)-interaction motif, which ensures ER distribution of mammalian Sac1 35, 42 ( Figure 2C ). The COPI-motif is not conserved in yeast or flies (Figure 2A, B) . Instead, yeast Sac1 has a unique 32 amino acid sequence that may be important for ER localization. 81 In addition, ER targeting requires the second TMD of yeast Sac1 (TMD2), which may interact directly with the ER resident protein Dpm1 81 ( Figure 2A ).
Sac1 Golgi localization relies on the ability of the SacN domain to interact with various Golgi-localized proteins (Figure 2A-C) . In yeast, SacN directly binds Vps74 44, 104 (Figure 2A ), whereas in mammals SacN associates with the MAPKs p38 and JNK3 to facilitate its Golgi localization 42, 98 ( Figure 2C ). In addition, mammalian SacN is essential for Sac1 oligomerization, which is a prerequisite for Golgi localization. 42 Furthermore, in HeLa cells, the first TMD of Sac1 (TMD1) also promotes Golgi localization 143 ( Figure 2C ). Membrane bilayers increase in width along the secretory pathway. 144 Hence, the length of Sac1 TMD1 may allow Sac1 to reach late Golgi membranes, while restricting its further movement along the secretory pathway. 143 Thus, Golgi-localization of Sac1 is controlled by 2 mechanisms: association of SacN with Golgi-localized proteins and partitioning of Sac1 due to membrane thickness and its TMD1.
Sac1 localization at MCS is dynamically regulated and involves multiple binding partners (Figure 4) Figure 4A ). When PM PI(4,5)P 2 levels are high, E-Syt2 binds PI(4,5)P 2 and acts as a tether to establish ER-PM contact sites containing Sac1. This leads to a local decrease in PM PI4P and PI(4,5)P 2 . In contrast, when PI(4,5)P 2 levels are low, E-Syt2 is released from the PM and ER-PM contact sites dissolve.
This prevents further hydrolysis of PM PI4P by Sac1 and allows PI(4,5)P 2 levels to recover. Although it is unclear whether endogenous Sac1 is enriched at MCS, this type of PIP-mediated feedback could serve as a general mechanism used by cells to regulate MCS and PIP distribution.
| Regulation of Sac1 activity at the level of protein structure or conformation
Sac1 is also regulated at the level of protein structure or conformation. The crystal structure of yeast Sac1 revealed a unique catalytic P-loop conformation, wherein the conserved catalytic cysteine and arginine residues are too far from each other to function in PIP hydrolysis. 39 This implies that a conformational change must occur to bring the catalytic residues close enough for Sac1 to dephosphorylate its substrate. Indeed, in vitro kinetic studies on the Sac1 phosphatase domain reveal Sac1 is an allosteric enzyme, usually in an inactive state. 148 Interestingly, anionic lipids such as PI, PS or phosphatidic acid (PA) activate Sac1 by binding the catalytic P-loop and inducing a conformational change that brings the catalytic cysteine and arginine residues close enough for PI4P hydrolysis. Hence, not only does Sac1 need to be properly expressed and correctly localized, it also needs to be activated by anionic lipids in the membrane.
This provides yet another layer of regulation for PI4P metabolism in vivo.
| ROLES FOR SAC1 IN LIPID HOMEOSTASIS

| Sac1 and sphingolipid biosynthesis
Early studies in yeast implicated Sac1 in sphingolipid biosynthesis.
Sphingolipids are extremely diverse in their form and function, with crucial roles in apoptosis, cell cycle regulation, cell motility, differentiation, adhesion and as structural components of cellular membranes. [149] [150] [151] De novo sphingolipid biosynthesis begins in the ER with the production of long-chain bases (LCBs) 150 ( Figure 5 ).
LCBs are generated by the serine palmitoyltransferases, Lcb1 and Lcb2, which condense serine and pamitoyl-coenzyme A. 152 In the ER, LCBs can be N-acylated or hydroxylated and acylated to form ceramides, which undergo vesicular and nonvesicular transport to the Golgi, where they are further modified to generate complex sphingolipids. 150 Modifications include addition of inositol phosphates (from PI) and mannose (from GDP-mannose) to produce complex sphingolipids, such as inositol phosphorylceramides (IPC), mannose-inositol-phosphoceramide (MIPC) and mannose-(inositol-
Yeast sac1 mutants exhibit a slow rate of sphingolipid biosynthesis, leading to elevated LCB and ceramide levels, as well as a dramatic decrease in complex sphingolipids. 149, 153 In addition, sac1 mutants are highly sensitive to impaired sphingolipid metabolism. 154 Sac1
Relationship of Sac1 to sphingolipid biosynthesis. Complex sphingolipid production begins in the ER where serine and palmitoyl-CoA are condensed to produce LCBs. LCB production requires the activity of Lcb1 and Lcb2, which are directly inhibited by Sac1 and other members of the SPOTS complex. LCBs are N-acylated to form ceramides. Ceramides are transported to the Golgi for further modification. At the Golgi, Sac1 contributes to complex sphingolipid production by providing PI through PI4P metabolism contributes directly and indirectly to flux through the sphingolipid biosynthesis pathway ( Figure 5 ). First, Sac1 directly modulates Lcb1/2 function. 149 Sac1 is a member of the SPOTS (Serine palmitoyltransferase, Orm1/2, Tsc3, Sac1) complex, which binds Lcb1/2 and negatively regulates LCB production in the ER. Abnormal sphingolipid levels result in Orm protein phosphorylation, which is thought to drive SPOTS complex oligomerization and modulate sphingolipid biosynthesis. 149, 155 Loss of Sac1 leads to synthetic lethality when orm genes are deleted, and sac1 mutants are highly resistant to the Lcb1/2 inhibitor myriocin. 149 Therefore, at least in yeast, Sac1 appears to be a direct negative regulator of sphingolipid precursor (ie, LCB, ceramide) production. Second, due to a lack of PI4P turnover, yeast sac1 mutants have decreased PI levels under steady state and pulse chase conditions. 23,24,,153 This reduces the amount of PI available for complex sphingolipid (ie, IPC, MIPC, M(IP) 2 C) biosynthesis and may contribute to the overall decrease in sphingolipid levels in Sac1-deficient cells. 153 Thus, Sac1 influences sphingolipid biosynthesis at the ER and the Golgi in distinct ways ( Figure 5 ). At the ER, Sac1
functions in a complex to negatively regulate LCB production in response to sphingolipid levels, whereas at the Golgi Sac1 regulates sphingolipid biosynthesis by modulating the availability of PI. It is currently unknown whether Sac1 plays a role in sphingolipid regulation in multicellular organisms, including Drosophila and humans.
| Sac1 and phospholipid homeostasis
In addition to decreased PI, yeast sac1 mutants have reduced amounts of cellular PS (40% reduction). 23, 154, 156 Pulse-chase labeling revealed that the rate of PS biosynthesis is reduced by half in sac1 mutants. 156 Loss of yeast Sac1 not only affects PS levels, but also disrupts PS distribution; instead of accumulating at the PM, PS is enriched on intracellular membranes. 117, 118, 156 Hence, normal PIP metabolism is important for maintenance of cellular PS. Interestingly, the reverse is also true. Yeast and mammalian cells lacking PS exhibit increased levels of PI4P, which accumulates at the Golgi and PM. 148, 157 Thus, PI4P and PS modulate each others' membrane localization and cellular levels in vivo.
The reciprocal regulation of these lipids probably occurs at ER-PM MCS where PS and PI4P are exchanged to establish lipid gradients and regulate lipid homeostasis [116] [117] [118] ( Figure 4A ). Continuous exchange of PS for PI4P, and PS enrichment at the PM (against its concentration gradient), requires PI4P hydrolysis. Without Sac1-mediated PI4P metabolism, PS cannot be transferred to the PM and instead accumulates at the ER, halting further PS production. 157 Interestingly, when Sac1 is present, PS directly activates Sac1 phosphatase activity in the membrane. 148 In this way, as PS levels increase at the ER, PS activates Sac1 to dephosphorylate PI4P, thereby stimulating the transfer of PS to the PM. In contrast, when PS is lacking, Sac1 will not be activated and PI4P levels will increase. Consequently, PS can regulate its own cellular distribution and abundance by being coupled to PIP metabolism and directly activating Sac1.
In addition to changes in PI and PS, sac1 mutants also show a slight increase in PC (10% elevation). 23, 154, 156 This increase in PC may be at the expense of PS synthesis, as these pathways share metabolic precursors. 156 However, it was also reported that sac1 mutants 98 it is tempting to speculate that Sac1 and JNK might act in a mutually antagonistic manner such that normal Sac1 activity at the ER reduces JNK signaling, whereas stressdependent JNK activation inhibits Sac1 activity at the ER.
| Sac1 attenuates Hedgehog signaling
In addition to JNK, Sac1 also regulates the Hedgehog (Hh) signaling pathway, which is conserved and required for a diverse array of developmental decisions. 159 Hh binding inactivates the cell surface indicating that a fine balance of PI4P synthesis and degradation is important. Notably, an increase in PI4P levels upon Hh signaling has been suggested, 41, 160 but requires further analysis.
| Sac1 regulates axon guidance in the embryonic central nervous system
Strong expression of Sac1 in the Drosophila embryonic central nervous system (CNS) suggested an important role in these cells. 161 The 3 receptor Robo. 162, 163 Genetic interaction studies show that deletion of one copy of slit or robo in sac1 mutant embryos greatly enhances sac1 midline crossing defects. 161 Given these observations, it is possible that PI4P regulation by Sac1 is required for anterograde trafficking or glycan processing of the receptor Robo. However, additional studies must be performed to test these hypotheses.
| Sac1 is required for postembryonic synaptic maturation and neuronal cell maintenance
A role for Drosophila Sac1 was also identified in postembryonic synapse formation. 34 β-spectrin and adducin. 34 These proteins are important for establishing proper NMJ and have been implicated in neurodegeneration. [165] [166] [167] Indeed, Sac1 knockdown by RNAi in the nervous system leads to neurodegeneration, accompanied by increased intracellular PI4P. 34 
| SAC1 FUNCTION IN MAMMALIAN CELLS
The roles of mammalian Sac1 have not been studied in vivo due to early embryonic lethality. 31 Consistent with this, knockdown of Sac1 
| Sac1, PI4P and adhesion in cancer cells
Sac1 maps to a segment on chromosome 3 (3p21.3) that is commonly lost in human cancers. 184 This chromosomal region is depleted in lung, kidney, head and neck, breast and bladder cancers, suggesting it contains tumor-suppressing genes, one of which could be Sac1. Interestingly, a recent study showed that elevated PI4P levels at the Golgi strongly influence breast cancer cells and that loss of Sac1 directly potentiates this effect. 178 Overexpression of the Golgi PI4P effector GOLPH3 also promotes cell migration. 178 This is not a surprise, as GOLPH3 has been identified previously as an oncogene. [185] [186] [187] [188] As discussed earlier, the yeast homolog of GOLPH3, Vps74, directly binds PI4P and Sac1 at the Golgi and is required to maintain Golgi resident proteins involved in protein and glycan processing. 44, 104, [106] [107] [108] In mammalian cells, GOLPH3 also binds PI4P and is needed for maintenance of Golgi glycosyltransferases. 109, 189, 190 Thus, it is possible that mammalian GOLPH3, like yeast Vps74, acts as a PI4P sensor to direct Sac1 activity at the Golgi. However, at least in the context of breast cancer cells, this is unlikely to be the case, as PI4P levels are elevated upon GOLPH3 overexpression. 178 Increased levels of GOLPH3 could compete with Sac1 for access to PI4P, thereby preventing Sac1 from dephosphorylating PI4P. As a result, Golgi PI4P levels could increase, leading to defective glycosylation and increased glycoprotein production, which are linked to cancer progression. 191 These studies show Sac1 is an important regulator of cell adhesion that helps attenuate cancer cell metastasis and migration. Future studies will be important to elucidate the mechanism by which Sac1 and PI4P control cancer progression.
| Viral replication requires PI4P hijacking and MCS manipulation
Positive-sense RNA viruses, such as hepatitis C virus (HCV) and human rhinoviruses (HRVs) co-opt cellular PI4P to drive infectious capacity. [179] [180] [181] [182] [183] Within infected cells, these viruses establish PI4P-and cholesterol-enriched "membranous webs" that act as platforms for viral replication.
PI4P is upregulated and essential during HCV infection. [192] [193] [194] [195] PI4P enrichment at viral replication sites is established by a dualmechanism that includes PI4K recruitment to promote PI4P production and Sac1 displacement to slow PI4P turnover. 196 The HCV nonstructural protein 5a (NS5A) is responsible for PI4P synthesis by recruiting PI4KIIIα and stimulating its activity at viral replication sites. 193, 194, 197, 198 In addition, NS5A recruits the Arf1 GTPase-activating protein (Arf1-GAP), 196 which is known to contribute to cargo sorting and COPI vesicle biogenesis. [199] [200] [201] Because Sac1 is a COPI cargo protein, NS5A
recruitment of Arf1-GAP probably displaces Sac1 from the Golgi, allowing increased PI4P at viral replication sites. 196 Thus, Sac1 and its ability to turn over PI4P normally inhibit HCV replication. In response, HCV has evolved ways to counter these antiviral effects. This highlights the possibility of Sac1 recruitment as a novel therapeutic target, as enhancing its localization and function at HCV replication sites may attenuate viral infection. 
| CONCLUSIONS AND OUTLOOK
Studies in budding yeast and cultured cells have revealed the importance of Sac1 in many cellular processes. However, we are only beginning to understand its functions in multicellular organisms.
Because Sac1 is essential in flies and mice, 31, 36 it has been difficult to study its roles in animal development. Thus, the consequences of Sac1 dysregulation in multicellular organisms are not well understood.
Future studies employing conditional alleles and cell-and tissuespecific genetic perturbations of Sac1 in animal models will provide much needed insight into its roles in important biological processes, including lipid homeostasis, cell differentiation, cell-cell signaling and disease progression.
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